Streetbeat News

Earnings

TYRA

Tyra Biosciences reported Q2 losses of $(0.31) per share, beating the analyst consensus estimate of $(0.34) by 8.82 percent. This represents a 13.89 percent improvement over losses of $(0.36) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:16 pm

TARS

Tarsus Pharmaceuticals reported Q2 losses of $(1.17) per share, a 387.5% decrease from the same period last year when losses were $(0.24) per share.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:15 pm

POAI

Predictive Oncology (NASDAQ:POAI) reported Q2 losses of $(0.98) per share, a 67.33% increase from $(3.00) per share YoY. The company also reported a 31.90% increase in sales to $490.11K from $371.59K YoY.

Portfolio Pulse from bharat@benzinga.com

August 10, 2023 | 9:15 pm

TBIO

Telesis Bio (NASDAQ:TBIO) reported Q2 earnings per share (EPS) of $(0.28), beating the analyst consensus estimate of $(0.32) by 12.5%. This is a 44% increase over losses from the same period last year. The company also reported quarterly sales of $8.65 million, beating the estimate of $8.60 million by 0.60%. This is a 53% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:15 pm

BCEL

Atreca (NASDAQ:BCEL) reported Q2 losses of $(0.49) per share, beating the analyst consensus estimate of $(0.57) by 14.04 percent. This represents a 31.94 percent increase over losses of $(0.72) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:14 pm

PBLA

Panbela Therapeutics reported Q2 losses of $7.95 per share, missing the analyst consensus estimate of $4.70 by 69.15%. This represents a 99.56% increase over losses from the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 10, 2023 | 9:14 pm

SVRA

Savara (NASDAQ:SVRA) reported Q2 losses of $(0.07) per share, a 16.67% increase in losses from $(0.06) per share during the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:14 pm

AEYE

AudioEye has projected its Q3 2023 revenue to be between $7.8M and $7.9M, which is lower than the estimated $8.3M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:14 pm

TLIS

Talis Biomedical (NASDAQ:TLIS) reported Q2 losses of $(8.27) per share, missing the analyst consensus estimate of $(0.73) by 1032.88 percent. However, this is a 45.41 percent increase over losses of $(15.15) per share from the same period last year. The company reported $581.00 thousand in sales this quarter, a 1.57 percent increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:13 pm

CALC

CalciMedica (NASDAQ:CALC) reported Q2 losses of $(1.11) per share, a 192.11% increase from $(0.38) per share losses in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:12 pm